Literature DB >> 29295862

Perturbed bone composition and integrity with disorganized osteoblast function in zinc receptor/Gpr39-deficient mice.

Milena Jovanovic1, Felix N Schmidt2, Gali Guterman-Ram1, Hanifeh Khayyeri3, Sahar Hiram-Bab4, Ayelet Orenbuch1, Svetlana Katchkovsky1, Anastasia Aflalo1, Hanna Isaksson3, Björn Busse2, Katharina Jähn2, Noam Levaot1,5.   

Abstract

Changes in bone matrix composition are frequently found with bone diseases and may be associated with increased fracture risk. Bone is rich in the trace element zinc. Zinc was established to play a significant role in the growth, development, and maintenance of healthy bones; however, the mechanisms underlying zinc effects on the integrity of the skeleton are poorly understood. Here, we show that the zinc receptor (ZnR)/Gpr39 is required for normal bone matrix deposition by osteoblasts. Initial analysis showed that Gpr39-deficient ( Gpr39-/-) mice had weaker bones as a result of altered bone composition. Fourier transform infrared spectroscopy analysis showed high mineral-to-matrix ratios in the bones of Gpr39-/- mice. Histologic analysis showed abnormally high numbers of active osteoblasts but normal osteoclast numbers on the surfaces of bones from Gpr39-/- mice. Furthermore, Gpr39-/- osteoblasts had disorganized matrix deposition in vitro with cultures exhibiting abnormally low collagen and high mineral contents, findings that demonstrate a cell-intrinsic role for ZnR/Gpr39 in these cells. We show that both collagen synthesis and deposition by Gpr39-/- osteoblasts are perturbed. Finally, the expression of the zinc transporter Zip13 and a disintegrin and metalloproteinase with thrombospondin motifs family of zinc-dependent metalloproteases that regulate collagen processing was downregulated in Gpr39-/- osteoblasts. Altogether, our results suggest that zinc sensing by ZnR/Gpr39 affects the expression levels of zinc-dependent enzymes in osteoblasts and regulates collagen processing and deposition.-Jovanovic, M., Schmidt, F. N., Guterman-Ram, G., Khayyeri, H., Hiram-Bab, S., Orenbuch, A., Katchkovsky, S., Aflalo, A., Isaksson, H., Busse, B., Jähn, K., Levaot, N. Perturbed bone composition and integrity with disorganized osteoblast function in zinc receptor/Gpr39-deficient mice.

Entities:  

Keywords:  GPCR; bone; collagen deposition; osteoblast; zinc

Mesh:

Substances:

Year:  2018        PMID: 29295862     DOI: 10.1096/fj.201700661RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy-The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene.

Authors:  Urszula Doboszewska; Jan Sawicki; Adam Sajnóg; Aleksandra Szopa; Anna Serefko; Katarzyna Socała; Mateusz Pieróg; Dorota Nieoczym; Katarzyna Mlyniec; Gabriel Nowak; Danuta Barałkiewicz; Ireneusz Sowa; Piotr Wlaź
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

Review 2.  Diverse and Complementary Effects of Ghrelin and Obestatin.

Authors:  Daniel Villarreal; Geetali Pradhan; Yu Zhou; Bingzhong Xue; Yuxiang Sun
Journal:  Biomolecules       Date:  2022-03-29

3.  Improved osteogenesis in rat femur segmental defects treated with human allograft and zinc adjuvants.

Authors:  Deboleena Kanjilal; Christopher Grieg; Maya Deza Culbertson; Sheldon S Lin; Michael Vives; Joseph Benevenia; J Patrick O'Connor
Journal:  Exp Biol Med (Maywood)       Date:  2021-05-26

Review 4.  Zinc as a Therapeutic Agent in Bone Regeneration.

Authors:  J Patrick O'Connor; Deboleena Kanjilal; Marc Teitelbaum; Sheldon S Lin; Jessica A Cottrell
Journal:  Materials (Basel)       Date:  2020-05-12       Impact factor: 3.623

Review 5.  The role of GPCRs in bone diseases and dysfunctions.

Authors:  Jian Luo; Peng Sun; Stefan Siwko; Mingyao Liu; Jianru Xiao
Journal:  Bone Res       Date:  2019-07-08       Impact factor: 13.567

Review 6.  The Zinc-Sensing Receptor GPR39 in Physiology and as a Pharmacological Target.

Authors:  Anna Laitakari; Lingzhi Liu; Thomas M Frimurer; Birgitte Holst
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

7.  Zinc Ameliorates the Osteogenic Effects of High Glucose in Vascular Smooth Muscle Cells.

Authors:  Laura A Henze; Misael Estepa; Burkert Pieske; Florian Lang; Kai-Uwe Eckardt; Ioana Alesutan; Jakob Voelkl
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

Review 8.  The Zinc Sensing Receptor, ZnR/GPR39, in Health and Disease.

Authors:  Michal Hershfinkel
Journal:  Int J Mol Sci       Date:  2018-02-01       Impact factor: 5.923

Review 9.  Role of GPR39 in Neurovascular Homeostasis and Disease.

Authors:  Yifan Xu; Anthony P Barnes; Nabil J Alkayed
Journal:  Int J Mol Sci       Date:  2021-07-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.